| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | -0.0082 | 0.8 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.8 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.8 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.0064 | 0.8 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.0081 | 0.8 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.0067 | 0.8 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.008 | 0.8 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.0066 | 0.8 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | -0.0069 | 0.8 |